Table 1.
Recent reported series of hepatectomy for intrahepatic cholangiocarcinoma
|
Survival rate (%) and MST |
|||||||
| Authors | Year | No | 1-yr | 3-yr | 5-yr | MST (mo) | Significant prognostic factors for survival |
| Okabayashi | 2001 | 60 | 68 | 35 | 29 | 19.6 | Number of nodules, lymph-node involvement, vascular invasion, symptomatic tumor |
| Chen | 1999 | 48 | 35.5 | 20.5 | 16.51 | ||
| 27.2 | 8.8 | 7.82 | |||||
| DeOliveira | 2007 | 44 | 40 | 28 | Surgical margin | ||
| Palik | 2008 | 97 | 74.9 | 51.8 | 31.1 | Number of nodules, surgical margin | |
| Inoue | 2000 | 52 | 63 | 36 | 36 | 18 | Surgical margin, lymph-node involvements, vascular invasion |
| Valverde | 1999 | 30 | 86 | 22 | 22 | 28 | Number of nodules, lymph-node involvements |
| Madariaga | 1998 | 34 | 67 | 40 | 35 | 19 | Number of nodules, surgical margin |
| Shimada | 2007 | 94 | 69.5 | 35.5 | 31.1 | 24 | Number of nodules, surgical margin, lymph-node involvements |
| Weber | 2001 | 33 | 55 | 31 | 37.4 | Vascular invasion | |
1
Data from intrahepatic cholangiocarcinoma patients with hepatolithiasis;
2
Data from intrahepatic cholangiocarcinoma patients without hepatolithiasis; MST: Median survival time.